Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential

Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential

Some of the most prevalent neurodegenerative disorders, including Alzheimer’s and Parkinson’s disease, are proteinopathies characterized by the accumulation of specific protein aggregates in the brain. Such misfolded protein aggregates can trigger modulation of the innate and adaptive immune systems...

Full description

Bibliographic Details
Main Authors:	Barbara Vuic, Tina Milos, Lucija Tudor, Marcela Konjevod, Matea Nikolac Perkovic, Maja Jazvinscak Jembrek, Gordana Nedic Erjavec, Dubravka Svob Strac
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Biomedicines
Subjects:	neurodegenerative diseases proteinopathies endocannabinoid system cannabinoid CB2 receptors neuroinflammation therapy
Online Access:	https://www.mdpi.com/2227-9059/10/12/3000

Similar Items

Cannabinoid CB2 receptors and spinal microglia are implicated in tingenone-mediated antinociception in mice
by: Clarice C.V. Moura, et al.
Published: (2021-01-01)

The Role of Cannabinoids in the Setting of Cirrhosis
by: Pratima Dibba, et al.
Published: (2018-06-01)

Neuronal Calcium and cAMP Cross-Talk Mediated by Cannabinoid CB1 Receptor and EF-Hand Calcium Sensor Interactions
by: Edgar Angelats, et al.
Published: (2018-07-01)

Cannabinoids and Their Receptors in Skin Diseases
by: Eun Hee Yoo, et al.
Published: (2023-11-01)

Cannabinoid Receptor Modulation of Neurogenesis: ST14A Striatal Neural Progenitor Cells as a Simplified In Vitro Model
by: Erika Cottone, et al.
Published: (2021-03-01)

Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
by: Ahmed Hasbi, et al.
Published: (2023-02-01)

Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility
by: Piotr Przybycień, et al.
Published: (2022-08-01)

Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
by: Kenneth B. Walsh, et al.
Published: (2021-11-01)

Down-Regulation of Cannabinoid Type 1 (CB1) Receptor and its Downstream Signaling Pathways in Metastatic Colorectal Cancer
by: Valeria Tutino, et al.
Published: (2019-05-01)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
by: Mikkel Søes Ibsen, et al.
Published: (2019-04-01)

Cannabinoid CB<sub>1</sub> Receptors in the Intestinal Epithelium Are Required for Acute Western-Diet Preferences in Mice
by: Bryant Avalos, et al.
Published: (2020-09-01)

Cannabinoid regulation of brain reward processing with an emphasis on the role of CB1 receptors: a step back into the future
by: George ePanagis, et al.
Published: (2014-07-01)

Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms
by: Barbara Vuic, et al.
Published: (2023-11-01)

Voltage dependence of the cannabinoid CB1 receptor
by: Esty Goldberger, et al.
Published: (2022-10-01)

Evaluation of cannabinoid receptors type 1–2 in periodontitis patients
by: Atefe Ataei, et al.
Published: (2022-10-01)

Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
by: Baswan SM, et al.
Published: (2020-12-01)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor
by: Monica Patel, et al.
Published: (2023-12-01)

Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice
by: Claudia Gonzalo-Consuegra, et al.
Published: (2024-05-01)

Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting
by: Nissar A. Darmani
Published: (2010-09-01)

Cannabinoid CB1 Receptor Expression and Localization in the Dorsal Horn of Male and Female Rat and Human Spinal Cord
by: Jessica Parnell, et al.
Published: (2023-07-01)

Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2
by: Bitya Raphael-Mizrahi, et al.
Published: (2022-05-01)

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis
by: Ana Cabranes, et al.
Published: (2005-11-01)

Microglial Cannabinoid CB<sub>2</sub> Receptors in Pain Modulation
by: Kangtai Xu, et al.
Published: (2023-01-01)

Editorial: The Canonical and Non-Canonical Endocannabinoid System as a Target in Cancer and Acute and Chronic Pain
by: Marialessandra Contino, et al.
Published: (2020-03-01)

Short overview on metabolomic approach and redox changes in psychiatric disorders
by: Gordana Nedic Erjavec, et al.
Published: (2018-04-01)

New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
by: Berhanu Geresu Kibret, et al.
Published: (2022-01-01)

CB1 Cannabinoid Receptor Signaling and Biased Signaling
by: Luciana M. Leo, et al.
Published: (2021-09-01)

Endocannabinoid System Components as Potential Biomarkers in Psychiatry
by: Francisco Navarrete, et al.
Published: (2020-04-01)

Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB<sub>1</sub> Receptor Antagonists after the Fall
by: Taryn Bosquez-Berger, et al.
Published: (2023-08-01)

CB1 cannabinoid receptor expression in the striatum: Association with corticostriatal circuits and developmental regulation
by: Vincent eVan Waes, et al.
Published: (2012-03-01)

Cannabinoid Modulation of the Stressed Hippocampus
by: Franciele F. Scarante, et al.
Published: (2017-12-01)

Tumor necrosis factor α, and agonist and antagonists of cannabinoid receptor type 1 and type 2 alter the immunophenotype of stem cells from human exfoliated deciduous teeth
by: Marizia Trevizani, et al.
Published: (2023-11-01)

Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects
by: Qing-Rong Liu, et al.
Published: (2020-12-01)

Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies
by: María Salud García-Gutiérrez, et al.
Published: (2022-05-01)

CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin
by: Pierre Cardinal, et al.
Published: (2014-10-01)

Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
by: Daniel A. Ladin, et al.
Published: (2016-10-01)

Cannabinoid CB2 Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer’s Disease
by: Samuel Ruiz de Martín Esteban, et al.
Published: (2022-04-01)

Neuroprotection and Beyond: The Central Role of CB1 and CB2 Receptors in Stroke Recovery
by: Bashir Bietar, et al.
Published: (2023-11-01)

Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma
by: Thomas Gruber, et al.
Published: (2021-04-01)

The potential role of cannabinoids in dermatology
by: Tabrez Sheriff, et al.
Published: (2020-11-01)